miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1

被引:18
作者
Zhao, Yiling [1 ]
Yang, Fenghua [2 ]
Li, Wenyuan [3 ]
Xu, Chunyan [4 ]
Li, Li [3 ]
Chen, Lifei [5 ]
Liu, Yancui [3 ]
Sun, Ping [3 ]
机构
[1] Affiliated Hongqi Hosp Mudanjiang Med Univ, Dept Ultrasound, Mudanjiang, Peoples R China
[2] Mudanjiang Med Univ, Dept Prevent & Hlth Stat, Mudanjiang, Peoples R China
[3] Mudanjiang Med Univ, Heilongjiang Higher Educ Inst, Key Lab Tumor Prevent & Treatment, Mudanjiang, Peoples R China
[4] Tumor Hosp Mudanjiang, Dept Pathol, Mudanjiang, Peoples R China
[5] First Affiliated Hosp Harbin Med Univ, Dept Ophthalmol, Harbin, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor necrosis factor receptor 1; miR-29a; MCF-7; cell; NF-KAPPA-B; BREAST-CANCER CELLS; FACTOR-ALPHA; CYCLIN D1; IN-VITRO; INFLAMMATION; EXPRESSION; APOPTOSIS; MICRORNA; ACTIVATION;
D O I
10.1177/1010428317692264
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor necrosis factor receptor 1 is the main receptor mediating many tumor necrosis factor-alpha-induced cellular events. Some studies have shown that tumor necrosis factor receptor 1 promotes tumorigenesis by activating nuclear factor-kappa B signaling pathway, while other studies have confirmed that tumor necrosis factor receptor 1 plays an inhibitory role in tumors growth by inducing apoptosis in breast cancer. Therefore, the function of tumor necrosis factor receptor 1 in breast cancer requires clarification. In this study, we first found that tumor necrosis factor receptor 1 was significantly increased in human breast cancer tissues and cell lines, and knockdown of tumor necrosis factor receptor 1 by small interfering RNA inhibited cell proliferation by arresting the cell cycle and inducing apoptosis. In addition, miR-29a was predicted as a regulator of tumor necrosis factor receptor 1 by TargetScan and was shown to be inversely correlated with tumor necrosis factor receptor 1 expression in human breast cancer tissues and cell lines. Luciferase reporter assay further confirmed that miR-29a negatively regulated tumor necrosis factor receptor 1 expression by binding to the 3' untranslated region. In our functional study, miR-29a overexpression remarkably suppressed cell proliferation and colony formation, arrested the cell cycle, and induced apoptosis in MCF-7 cell. Furthermore, in combination with tumor necrosis factor receptor 1 transfection, miR-29a significantly reversed the oncogenic role caused by tumor necrosis factor receptor 1 in MCF-7 cell. In addition, we demonstrated that miR-29a suppressed MCF-7 cell growth by inactivating the nuclear factor-kappa B signaling pathway and by decreasing cyclinD1 and Bcl-2/Bax protein levels. Taken together, our results suggest that miR-29a is an important regulator of tumor necrosis factor receptor 1 expression in breast cancer and functions as a tumor suppressor by targeting tumor necrosis factor receptor 1 to influence the growth of MCF-7 cell.
引用
收藏
页数:11
相关论文
共 46 条
[1]   Tumor necrosis factor receptor associated factor-4: An adapter protein overexpressed in metastatic prostate cancer is regulated by microRNA-29a [J].
Ahmed, Fozia ;
Shiraishi, Takumi ;
Vessella, Robert L. ;
Kulkarni, Prakash .
ONCOLOGY REPORTS, 2013, 30 (06) :2963-2968
[2]   Tumor Necrosis Factor Receptor Expression and Signaling in Renal Cell Carcinoma [J].
Al-Lamki, Rafia S. ;
Sadler, Timothy J. ;
Wang, Jun ;
Reid, Martin J. ;
Warren, Anne Y. ;
Movassagh, Mehregan ;
Lu, Wanhua ;
Mills, Ian G. ;
Neal, David E. ;
Burge, Johanna ;
Vandenebeele, Peter ;
Pober, Jordan S. ;
Bradley, John R. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (02) :943-954
[3]   Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ [J].
Barham, Whitney ;
Chen, Lianyi ;
Tikhomirov, Oleg ;
Onishko, Halina ;
Gleaves, Linda ;
Stricker, Thomas P. ;
Blackwell, Timothy S. ;
Yull, Fiona E. .
BMC CANCER, 2015, 15
[4]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]   Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression [J].
Basseres, D. S. ;
Baldwin, A. S. .
ONCOGENE, 2006, 25 (51) :6817-6830
[6]   MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer [J].
Bertoli, Gloria ;
Cava, Claudia ;
Castiglioni, Isabella .
THERANOSTICS, 2015, 5 (10) :1122-1143
[7]   Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications [J].
Bower, Julienne E. ;
Lamkin, Donald M. .
BRAIN BEHAVIOR AND IMMUNITY, 2013, 30 :S48-S57
[8]   Increased expression of NF-κB subunits in human pancreatic cancer cells [J].
Chandler, NM ;
Canete, JJ ;
Callery, MP .
JOURNAL OF SURGICAL RESEARCH, 2004, 118 (01) :9-14
[9]   The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans [J].
Charles, Kellie A. ;
Kulbe, Hagen ;
Soper, Robin ;
Escorcio-Correia, Monica ;
Lawrence, Toby ;
Schultheis, Anne ;
Chakravarty, Probir ;
Thompson, Richard G. ;
Kollias, George ;
Smyth, John F. ;
Balkwill, Frances R. ;
Hagemann, Thorsten .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) :3011-3023
[10]   miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A [J].
Chen, Ling ;
Xiao, Hong ;
Wang, Zong-Hua ;
Huang, Yi ;
Liu, Zi-Peng ;
Ren, Hui ;
Song, Hang .
BMB REPORTS, 2014, 47 (01) :39-44